Feno levels may predict complications among patients with nontuberculous mycobacterial pulmonary disease: Study Dr. Shravani Dali13 Jun 2024 10:00 PM ISTFeno levels may predict complications among patients with nontuberculous mycobacterial pulmonary disease suggests a study published in the BMC...
Inhaled seralutinib significantly decreased pulmonary vascular resistance and benefit PAH patients: Study Dr. Shravani Dali12 Jun 2024 9:00 PM ISTInhaled seralutinib significantly decreased pulmonary vascular resistance and benefit PAH patients suggests a study published in The Lancet...
Increasing prevalence of nicotine vaping associated with respiratory symptoms among youth, suggests study Jacinthlyn Sylvia11 Jun 2024 8:15 PM ISTNicotine vaping is rising among youth and has triggered cautions over its potential health repercussions, particularly respiratory issues. A recent...
AstraZeneca Tagrisso gets USFDA priority review for unresectable, Stage III EGFR-mutated lung cancer Ruchika Sharma11 Jun 2024 11:39 AM ISTAstraZeneca's supplemental New Drug Application (sNDA) for TAGRISSO (osimertinib) has been accepted and granted Priority Review in the US for the...
Persisting exercise ventilatory inefficiency linked to unfavorable CV outcomes in subjects recovering from COVID-19: Study Dr. Shravani Dali10 Jun 2024 8:15 PM ISTPersisting exercise ventilatory inefficiency linked to unfavourable CV outcomes in subjects recovering from COVID-19 suggests a study published in the...
15-day Paxlovid regimen safe but adds no clear benefit for long-COVID patients: Stanford Medicine trial Dr. Kamal Kant Kohli10 Jun 2024 9:45 AM ISTIn a clinical trial conducted by Stanford Medicine investigators and their colleagues, a 15-day course of Paxlovid-an antiviral drug combination...
USFDA approves expanded age indication for GSK RSV vaccine Arexvy for adults aged 50-59 at increased risk Ruchika Sharma9 Jun 2024 10:00 AM ISTLondon: GSK plc has announced that the US Food and Drug Administration (FDA) has approved Arexvy (Respiratory Syncytial Virus (RSV) Vaccine,...
Budesonide/Glycopyrrolate/Formoterol show promising results in COPD management in real world study Dr. Shravani Dali7 Jun 2024 8:30 PM ISTBudesonide/Glycopyrrolate/Formoterol show promising results in COPD management in real-world study suggests a study published in the International...
Ministry of Mines collaborates with Central TB Division for elimination of Tuberculosis Kajal Rajput7 Jun 2024 4:45 PM ISTNew Delhi: Ministry of Mines and Central TB Division of Ministry of Health and Family Welfare signed a Memorandum of Understanding in New Delhi for...
Brensocatib may reduce frequency of pulmonary exacerbations in patients with non-cystic fibrosis bronchiectasis, uncovers phase 3 ASPEN study Dr. Kamal Kant Kohli6 Jun 2024 8:15 PM ISTInsmed Incorporated a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced...
Extreme heat associated with increased hospital visits for children with asthma, states study Dr. Kamal Kant Kohli6 Jun 2024 8:15 PM ISTFor children seeking care at a California urban pediatric health center, extreme heat events were associated with increased asthma hospital visits,...
Ground-glass opacities on CT lung cancer imaging encouraging prognostic factor in non-small cell lung cancer: Study Medha Baranwal5 Jun 2024 8:15 PM ISTChina: A recent study published in the American Journal of Roentgenology has brought attention to the significance of minor (<=10%) ground-glass...
